1 Hahn, S., Jackson, L.G. and Zimmermann, B.G. (2010) Prenatal diagnosis of fetal aneuploidies: post-genomic developments. Genome Medicine 2, 50
2 Bianchi, D.W. (2010) From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood. Prenatal Diagnosis 30, 622-623
3 Ferguson-Smith, M.A. and Bianchi, D.W. (2010) Prenatal diagnosis: past, present, and future. Prenatal Diagnosis 30, 601-604
4 Lo, Y.M. (2010) Noninvasive prenatal diagnosis in 2020. Prenatal Diagnosis 30, 702-703
5 Morris, J.K. and Alberman, E. (2009) Trends in Down’s syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. British Medical Journal 339, b3794
6 Philip, J. et al. (2004) Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstetrics and Gynecology 103, 1164-1173
7 Chiu, R.W. et al. (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. British Medical Journal 342, c7401
8 Jackson, L. and Pyeritz, R.E. (2011) Molecular technologies open new clinical genetic vistas. Science Translational Medicine 3, 65–62
9 Lo, Y.M. et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487
10 van der Schoot, C.E., Hahn, S. and Chitty, L.S. (2008) Non-invasive prenatal diagnosis and determination of fetal Rh status. Seminars in Fetal and Neonatal Medicine 13, 63-68
11 Chitty, L.S. et al. (2008) SAFE–the special noninvasive advances in fetal and neonatal evaluation network: aims and achievements. Prenatal Diagnosis 28, 83-88
12 Finning, K. et al. (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. British Medical Journal 336, 816-818
13 Gautier, E. et al. (2005) Fetal RhD genotyping by maternal serum analysis: a two-year experience. American Journal of Obstetrics and Gynecology 192, 666-669
14 Maddocks, D.G. et al. (2009) The SAFE project: towards non-invasive prenatal diagnosis. Biochemical Society Transactions 37, 460-465
15 Lo, Y.M. (2009) Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. British Journal of Obstetrics and Gynecology 116, 152-157
16 Krentz, S.E. and Pilskaln, S.M. (1988) Product life cycle: still a valid framework for business planning. Top Health Care Finance 15, 40-48
17 Lo, Y.M. et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. American Journal of Human Genetics 62, 768-775
18 Zimmermann, B. et al. (2005) Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clinical Chemistry 51, 1598-1604
19 Sikora, A. et al. (2010) Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clinical Chemistry 56, 136-138
20 Chan, K.C. et al. (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clinical Chemistry 50, 88-92
21 Li, Y. et al. (2004) Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clinical Chemistry 50, 1002-1011
22 Hahn, S. and Zimmermann, B.G. (2010) Cell-free DNA in maternal plasma: has the size-distribution puzzle been solved? Clinical Chemistry 56, 1210-1211
23 Fan, H.C. et al. (2010) Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clinical Chemistry 56, 1279-1286
24 Lo, Y.M. et al. (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2, 61ra91
25 Li, Y. et al. (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using size- fractionated cell-free DNA in maternal plasma. Journal of the American Medical Association 293, 843-849
26 Li, Y. et al. (2004) Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma – case report. Prenatal Diagnosis 24, 896-898
27 Li, Y. et al. (2007) Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenatal Diagnosis 27, 11-17
28 Li, Y. et al. (2006) Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 27, 3889-3896
29 Flori, E. et al. (2004) Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Human Reproduction 19, 723-724
30 Alberry, M. et al. (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenatal Diagnosis 27, 415-418
31 Chim, S.S. et al. (2008) Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clinical Chemistry 54, 500-511
32 Chim, S.S. et al. (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America 102, 14753-14758
33 Chiu, R.W. et al. (2007) Hypermethylation of RASSF1A in human and rhesus placentas. American Journal of Pathology 170, 941-950
34 Ehrich, M. et al. (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. American Journal of Obstetrics and Gynecology 204, 205.e1-205.e11
35 Lo, Y.M. et al. (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nature Medicine 13, 218-223
36 Gandhi, S.J. et al. (2010) Transcription of functionally related constitutive genes is not coordinated. Nature Structural and Molecular Biology 18, 27-34
37 Lionnet, T. and Singer, R.H. (2010) Transcription, one allele at a time. Genome Biology 11, 129
38 Tong, Y.K. et al. (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical
and empirical considerations. Clinical Chemistry 52, 2194-2202
39 Tong, Y.K. et al. (2010) Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clinical Chemistry 56, 90-98